Literature DB >> 15596395

Behavioral effects of serotonin and serotonin agonists in two crayfish species, Procambarus clarkii and Orconectes rusticus.

A J Tierney1, M A Greenlaw, K Dams-O'Connor, S D Aig, A M Perna.   

Abstract

Exogenous serotonin elicits several behaviors in Procambarus clarkii, including a flexed, elevated posture, reduced locomotion, and changes in aggressive behavior. We conducted experiments to determine if several serotonin agonists mimicked the behavioral effects of serotonin in two crayfish species, P. clarkii and Orconectes rusticus. Drugs tested were 1-(3-Chlorophenyl)-piperazine dihydrochloride (mCPP), Oxymetazoline, 2,5-dimethoxy-4-iodoamphetamine (DOI), CGS-12066A, and (+/-)-8-hydroxy-2-(di-n-dipropylamino) tetralin (8-OH-DPAT). In P. clarkii, mCPP most closely mimicked the effects of serotonin, significantly increasing the performance of the flexed, elevated posture and reducing locomotion; 8-OH-DPAT significantly reduced locomotion as well. Both of these drugs produced significant increases in elevated posture and decreases in locomotion in O. rusticus, and in this species, the drugs at test concentrations were more effective in eliciting these effects than serotonin. The effects of the drugs on behaviors performed during fighting bouts were variable. In both species, only 8-OH-DPAT significantly reduced several agonistic behaviors, and no agonist or 5-HT itself produced significant increases in agonistic behavior.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15596395     DOI: 10.1016/j.cbpb.2004.10.010

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Mol Integr Physiol        ISSN: 1095-6433            Impact factor:   2.320


  8 in total

1.  Octopamine and serotonin have opposite effects on antipredator behavior in the orb-weaving spider, Larinioides cornutus.

Authors:  Thomas C Jones; Tamer S Akoury; Christopher K Hauser; Michael F Neblett; Brent J Linville; Andrea A Edge; Nathaniel O Weber
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2011-04-12       Impact factor: 1.836

2.  Molecular cloning and characterization of crustacean type-one dopamine receptors: D1alphaPan and D1betaPan.

Authors:  Merry C Clark; Deborah J Baro
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2006-01-19       Impact factor: 2.231

3.  Identification of putative amine receptor complement in the eyestalk of the crayfish, Procambarus clarkii.

Authors:  Andrew E Christie
Journal:  Invert Neurosci       Date:  2019-09-23

4.  Conservation of structure, signaling and pharmacology between two serotonin receptor subtypes from decapod crustaceans, Panulirus interruptus and Procambarus clarkii.

Authors:  Nadja Spitzer; Donald H Edwards; Deborah J Baro
Journal:  J Exp Biol       Date:  2008-01       Impact factor: 3.312

5.  Serotonin and synaptic transmission at invertebrate neuromuscular junctions.

Authors:  Wen-Hui Wu; Robin L Cooper
Journal:  Exp Neurobiol       Date:  2012-09-17       Impact factor: 3.261

6.  Effects of miR-143 and its target receptor 5-HT2B on agonistic behavior in the Chinese mitten crab (Eriocheir sinensis).

Authors:  Yang-Yang Pang; Gen-Yong Huang; Ya-Meng Song; Xiao- Zhe Song; Jia-Huan Lv; Long He; Chao Niu; Ao-Ya Shi; Xing-Liang Shi; Yong-Xu Cheng; Xiao-Zhen Yang
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

7.  GYRKPPFNGSIFamide (Gly-SIFamide) modulates aggression in the freshwater prawn Macrobrachium rosenbergii.

Authors:  Nietzell Vázquez-Acevedo; Nilsa M Rivera; Alejandra M Torres-González; Yarely Rullan-Matheu; Eduardo A Ruíz-Rodríguez; María A Sosa
Journal:  Biol Bull       Date:  2009-12       Impact factor: 1.818

8.  Cloning and immunoreactivity of the 5-HT 1Mac and 5-HT 2Mac receptors in the central nervous system of the freshwater prawn Macrobrachium rosenbergii.

Authors:  Nietzell Vázquez-Acevedo; Dalynés Reyes-Colón; Eduardo A Ruíz-Rodríguez; Nilsa M Rivera; Joshua Rosenthal; Andrea B Kohn; Leonid L Moroz; María A Sosa
Journal:  J Comp Neurol       Date:  2009-04-01       Impact factor: 3.215

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.